Scientists investigating a molecule known to play a key role in causing colon cancer have made a series of ground-breaking discoveries that could have major implications for future treatment of the disease, responsible for 655,000 deaths worldwide per year. Their findings are published in the journal Cancer Research, today (Wednesday 1 October 2008).
Lees meer..

While cholesterol-lowering drugs and new technologies have significantly advanced the nation’s battle against heart disease, it continues to rank as the No. 1 killer of U.S. men and women. But if researchers at the La Jolla Institute for Allergy & Immunology (LIAI) have their way, the body’s immune system will become an important player in reducing heart disease.
Lees meer..

Last week, the U.S. House of Representatives passed the Ryan Haight Online Pharmacy Consumer Protection Act of 2008. In response, Stephen L. Giroux, R.Ph, National Community Pharmacists Association (NCPA) President and an upstate New York pharmacy owner, issued the following statement: “Rogue online drug operators should no longer go unregulated. This legislation to clamp down on illegal online operators is the first step in the right direction, and I urge the U.S.
Lees meer..

Experiments on lab cultured cells and mice suggested that high amounts of vitamin C derivative at the cellular level, as results from taking supplements, may actually reduce the effect of anti-cancer drugs by helping the cancer cells live longer.
Lees meer..

Audience: Neurologists, cardiologists, consumers[Posted 09/30/2008] An FDA analysis provides new evidence that the use of statins does not increase incidence of amyotrophic lateral sclerosis (ALS), a neurodegenerative disease often referred to as…
Audience: Neurologists, cardiologists, consumers[Posted 09/30/2008] An FDA analysis provides new evidence that the use of statins does not increase incidence of amyotrophic lateral sclerosis (ALS), a neurodegenerative disease often referred to as…
Lees meer..

An expert group, set up by Health Minister Edwina Hart, to look at the issues around funding drugs on the NHS that are not approved by NICE will report on its findings and recommendations in the New Year. The group, led by Professor Philip Routledge, the chair of the All Wales Medicines Strategy Group, has been canvassing views of health professionals and patient representatives over the summer.
Lees meer..

Researchers from the “Centro de Biología Molecular Severo Ochoa” (CSIC-UAM), Córdoba University and the “Instituto de Biomedicina de Valencia” (CSIC) have analysed the degree of preservation in the skeletal muscles of paraplegic rats treated with a transplant of Olfactory bulb glial cells (OBG). Spinal chord injuries represent a serious and irreversible handicap that is sadly frequent in our society.
Lees meer..

The Scripps Research Institute, one of the world’s largest independent, non-profit biomedical research organizations, and the International AIDS Vaccine Initiative (IAVI), the world’s only global non-profit organization focused solely on AIDS vaccine development, today announced the establishment of a new research center dedicated exclusively to solving the most pressing challenge facing AIDS vaccine researchers today.
Lees meer..

Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV) announced that it has signed a development, license and commercialization agreement with Teva Pharmaceutical Industries Ltd. for the exclusive, worldwide rights to pagoclone.
Lees meer..

Gene Network Sciences, Inc. (GNS) today announced that it has entered into an agreement with Biogen Idec under which GNS will use its proprietary REFS™ software platform to process clinical data provided by Biogen Idec to identify targets and biomarkers in inflammation. A forward simulation model generated directly from the Biogen Idec data will be licensed to Biogen Idec at the conclusion of this project. Financial terms of the agreement were not disclosed.
Lees meer..